An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you're connecting to the official website and that any information you provide is encrypted and sent securely.
If you are a Veteran in crisis or concerned about one, connect with our caring, qualified responders for confidential help. Many of them are Veterans themselves.
Catalano LT, Green MF. Approaches to Studying and Improving Social Motivation in Schizophrenia. Schizophrenia Bulletin. 2023 Sep 7; 49(5):1108-1111.
Catalano LT, Green MF. Social Motivation in Schizophrenia: What's Effort Got to Do With It? Schizophrenia Bulletin. 2023 Sep 7; 49(5):1127-1137.
Hasson-Ohayon I, Igra L, Lavi-Rotenberg A, Goldzweig G, Lysaker PH. Findings from a randomized controlled trial of Metacognitive Reflection and Insight Therapy for people with schizophrenia: Effects on metacognition and symptoms. Psychology and psychotherapy. 2023 Jul 31.
Abplanalp SJ, Lee J, Horan WP, Kern RS, Penn DL, Green MF. A Bayesian Network Approach to Social and Nonsocial Cognition in Schizophrenia: Are Some Domains More Fundamental than Others? Schizophrenia Bulletin. 2023 Jul 4; 49(4):997-1006.
Reddy LF, Glynn SM, McGovern JE, Sugar CA, Reavis EA, Green MF. A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT. The American journal of psychiatry. 2023 May 1; 180(5):367-376.
Minor KS, Lundin NB, Myers EJ, Fernández-Villardón A, Lysaker PH. Automated measures of speech content and speech organization in schizophrenia: Test-retest reliability and generalizability across demographic variables. Psychiatry Research. 2023 Feb 1; 320:115048.
Horan WP, Catalano LT, Green MF. An Update on Treatment of Cognitive Impairment Associated with Schizophrenia. Current topics in behavioral neurosciences. 2023 Jan 1; 63:407-436.
Riedel P, Lee J, Watson CG, Jimenez AM, Reavis EA, Green MF. Reorganization of the functional connectome from rest to a visual perception task in schizophrenia and bipolar disorder. Psychiatry research. Neuroimaging. 2022 Dec 1; 327:111556.
Buck B, Gagen EC, Halverson TF, Nagendra A, Ludwig KA, Fortney JC. A systematic search and critical review of studies evaluating psychometric properties of patient-reported outcome measures for schizophrenia. Journal of psychiatric research. 2022 Mar 1; 147:13-23.
Kukla M, Arellano-Bravo C, Lysaker PH. "I'd Be A Completely Different Person if I Hadn't Gone to Therapy": A Qualitative Study of Metacognitive Therapy and Recovery Outcomes in Adults with Schizophrenia. Psychiatry. 2021 Nov 11; 85(3):259-269.
Davis BJ, Lysaker PH, Salyers MP, Minor KS. The insight paradox in schizophrenia: A meta-analysis of the relationship between clinical insight and quality of life. Schizophrenia Research. 2020 Sep 1; 223:9-17.
Kern RS, Reddy LF, Cohen AN, Young AS, Green MF. Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia. Psychiatry Research. 2020 Sep 1; 291:113258.
Marggraf MP, Lysaker PH, Salyers MP, Minor KS. The link between formal thought disorder and social functioning in schizophrenia: A meta-analysis. European psychiatry : the journal of the Association of European Psychiatrists. 2020 Mar 23; 63(1):e34.
Buck B, Gagen EC, Luther L, Kukla M, Lysaker PH. Dynamic relationships between emotional distress, persecutory ideation, and metacognition in schizophrenia. Journal of Clinical Psychology. 2020 Apr 1; 76(4):716-724.
Bonfils KA, Haas GL, Salyers MP. Emotion-specific performance across empathy tasks in schizophrenia: Influence of metacognitive capacity. Schizophrenia research. Cognition. 2020 Mar 1; 19:100139.
Cohen AN, Rocchio R. Developing and Initial Testing of a Mobile App Delivering an Evidence-based Weight Management Program to Veterans with Schizophrenia: CoachToFit. Spotlight on Mental Health Centers of Excellence [Cyberseminar]. VA HSR&D. 2019 Feb 11.
Cohen AN. Addressing Obesity in the Population with Schizophrenia. American Psychiatric Association; 2019 Jan 31. Available from: https://education.smiadviser.org/Users/ProductDetails.aspx?ActivityID=6451.
Young AS, Cohen AN, Hamilton AB, Hellemann G, Reist C, Whelan F. Implementing Patient-Reported Outcomes to Improve the Quality of Care for Weight of Patients with Schizophrenia. The journal of behavioral health services & research. 2019 Jan 1; 46(1):129-139.
Luther L, Fischer MW, Firmin RL, Salyers MP. Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis. Schizophrenia Research. 2019 Apr 1; 206:27-36.
Lysaker P, Hamm JA, Vohs J, Kukla ME, Pattison ML, Leonhardt BL, Lysaker JT. Understanding the course of self-disorders and alterations in self-experience in schizophrenia: Implications from research on metacognition. Current psychiatry reviews. 2018 Dec 1; 14(3):DOI : 10.2174/1573400514666180816113159.
Kukla M, Bell MD, Lysaker PH. A randomized controlled trial examining a cognitive behavioral therapy intervention enhanced with cognitive remediation to improve work and neurocognition outcomes among persons with schizophrenia spectrum disorders. Schizophrenia Research. 2018 Jul 1; 197:400-406.
Hansen RA, Hohmann N, Maciejewski ML, Domino ME, Ray N, Mahendraratnam N, Farley JF. Continuity of Medication Management among Adults with Schizophrenia and Comorbid Cardiometabolic Conditions. Journal of pharmaceutical health services research: an official journal of the Royal Pharmaceutical Society of Great Britain. 2018 Mar 1; 9(1):13-20.
Humphreys K. A Review of the Impact of Exclusion Criteria on the Generalizability of Schizophrenia Treatment Research. Clinical schizophrenia & related psychoses. 2017 Apr 1; 11(1):49-57.
Pedersen ER, Huang W, Cohen AN, Young AS. Alcohol use and service utilization among veterans in treatment for schizophrenia. Psychological Services. 2018 Feb 1; 15(1):21-30.
Bradford DW, Goulet J, Hunt M, Cunningham NC, Hoff R. A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer. The Journal of clinical psychiatry. 2016 Dec 1; 77(12):e1626-e1630.
Rotondi AJ. Development and Usability Testing of a Web-Based Smoking Cessation Treatment for Smokers with Schizophrenia. Internet interventions. 2016 May 21; 444-447.
Kasckow JW, Chen C, Rajj TK, Fraser C. Late Life Schizophrenia: Advances in Research. Presented at: American Association for Geriatric Psychiatry Annual Meeting; 2016 Mar 17; Washington, DC.
Radhakrishnan R, Kiluk BD, Tsai J. A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia. The Psychiatric quarterly. 2016 Mar 1; 87(1):57-62.
Daniels KS, Kasckow JW. Reduction of Medical Hospitalizations in Veterans With Schizophrenia Using Home Telehealth. Presented at: American Psychiatric Association Institute on Psychiatric Services Annual Conference; 2015 Oct 10; New York, NY.
Doshi JA, Pettit AR, Stoddard JJ, Zummo J, Marcus SC. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge. Journal of Clinical Psychopharmacology. 2015 Aug 1; 35(4):442-6.
Cohen AN, Chinman MJ, Hamilton AB, Whelan F, Young AS. Patient-facing kiosks for Veterans with schizophrenia: reducing risk by dynamically identifying service needs. Paper presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
Grubaugh AL, Knapp RG, Ellis C, Veronee K. Reactions to Exposure Therapy for PTSD Among Patients with Schizophrenia. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
Tan Y, Horvitz-Lennon M, Gellad WF, Normand SL, Donohue JM. Prescribing of clozapine and antipsychotic polypharmacy for schizophrenia in a large Medicaid program. Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2015 May 19; Philadelphia, PA.
Ganzini LK, Gross A. Cancer Care for Patients with Schizophrenia. In: Holland JC, Breitbart WS, Butow PN, Jacobsen PB, Loscalzo MJ, McCorkle R, editors. Psycho-Oncology. New York, NY: Oxford University Press; 2015. Chapter 44. 345-355 p.
Predmore ZS, Mattke S, Horvitz-Lennon M. Improving antipsychotic adherence among patients with schizophrenia: savings for states. Psychiatric services (Washington, D.C.). 2015 Apr 1; 66(4):343-5.
Kasckow JW. Pharmacologic and psychosocial treatments for the older patient with schizophrenia: the evidence base. Presented at: American Association for Geriatric Psychiatry Annual Meeting; 2015 Mar 28; New Orleans, LA.
Birgenheir DG, Ganoczy D, Bowersox NW. Service utilization among veterans with schizophrenia and a comorbid anxiety disorder. Psychiatric services (Washington, D.C.). 2014 Nov 1; 65(11):1354-9.
Armstrong NP, Cohen AN, Hellemann G, Reist C, Young AS. Validating a brief version of the Mental Health Recovery Measure for individuals with schizophrenia. Psychiatric services (Washington, D.C.). 2014 Sep 1; 65(9):1154-9.
Fontanella CA, Guada J, Phillips G, Ranbom L, Fortney JC. Individual and contextual-level factors associated with continuity of care for adults with schizophrenia. Administration and policy in mental health. 2014 Sep 1; 41(5):572-87.
Kukla M, Davis LW, Lysaker PH. Cognitive behavioral therapy and work outcomes: correlates of treatment engagement and full and partial success in schizophrenia. Behavioural and cognitive psychotherapy. 2014 Sep 1; 42(5):577-92.
Kukla M, Lysaker PH, Roe D. Strong subjective recovery as a protective factor against the effects of positive symptoms on quality of life outcomes in schizophrenia. Comprehensive psychiatry. 2014 Aug 1; 55(6):1363-8.
Lysaker P, Hillis J, Leonhardt BL, Kukla ME, Buck KD. Metacognition in schizophrenia spectrum disorders: Methods of assessment and associations with psychosocial function, neurocognition, symptoms, and cognitive style. In: Social cognition and metacognition in schizophrenia: Psychopathology and treatment approaches. San Diego, CA: Academic Press; 2014. Chapter 6. 99-110 p.
Niv N, Cohen AN, Hamilton A, Reist C, Young AS. Effectiveness of a psychosocial weight management program for individuals with schizophrenia. The journal of behavioral health services & research. 2014 Jul 1; 41(3):370-80.
Cohen C, Kasckow JW. The emerging crisis in the care of older adults with schizophrenia: what can be done. Presented at: American Psychiatric Association Annual Workshop; 2014 May 5; New York, NY.
Sanghani S, Kasckow JW, Golshan S, Zisook S. Antidepressant response in the treatment of subsyndromal depression in middle aged and older patients with schizophrenia. Poster session presented at: American Psychiatric Association Annual Meeting; 2014 May 5; New York, NY.
Kasckow J, Golshan S, Zisook S. Does age moderate the relationship between depressive symptoms and suicidal ideation in middle-aged and older patients with schizophrenia and subthreshold depression? The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2014 May 1; 22(5):437-41.
Kasckow JW, Zickmund SL, Walch A, Rotondi AJ, Chinman MJ, Fox L, Haas GL. Optimizing scripted dialogues for an e-health intervention for middle aged and older suicidal Veterans with schizophrenia. Paper presented at: American Association for Geriatric Psychiatry Annual Meeting; 2014 Mar 16; Orlando, FL.
Tsai J, Rosenheck RA. Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Research. 2013 Nov 30; 210(1):16-20.
Birgenheir DG. Pain conditions among veterans with schizophrenia or bipolar disorder. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 23; Nashville, TN.
Kukla M, Lysaker PH, Salyers MP. Do persons with schizophrenia who have better metacognitive capacity also have a stronger subjective experience of recovery? Psychiatry Research. 2013 Oct 30; 209(3):381-5.
Thwin SS, Hermes E, Lew R, Barnett P, Liang M, Valley D, Rosenheck R. Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures. Psychiatry Research. 2013 Oct 30; 209(3):291-6.
Kasckow JW, Zickmund SL, Walch A, Rotondi AJ, Chinman MJ, Fox L, Haas GL. Optimizing scripted dialogues for an e-health intervention for suicidal Veterans with major depression or schizophrenia: a ‘user design’ approach. Poster session presented at: American Psychiatric Association Institute on Psychiatric Services Annual Conference; 2013 Oct 11; Philadelphia, PA.
Salyers MP, Matthias MS, Sidenbender S, Green A. Patient activation in schizophrenia: insights from stories of illness and recovery. Administration and policy in mental health. 2013 Sep 1; 40(5):419-27.
Hamm JA, Hasson-Ohayon I, Kukla M, Lysaker PH. Individual psychotherapy for schizophrenia: trends and developments in the wake of the recovery movement. Psychology research and behavior management. 2013 Aug 6; 6:45-54.
Lysaker PH, Vohs J, Hasson-Ohayon I, Kukla M, Wierwille J, Dimaggio G. Depression and insight in schizophrenia: comparisons of levels of deficits in social cognition and metacognition and internalized stigma across three profiles. Schizophrenia Research. 2013 Aug 1; 148(1-3):18-23.
Berges A, Ong M, Goldberg R. Schizophrenia. In: Ferri F, editor. Ferri’s Clinical Advisor 2014: 5 Books in 1. 2014 ed. Philadelphia, PA: Elsevier Mosby; 2013. 993-4 p.
Ganzini LK. Advances in Medical Care for Patients with Schizophrenia. Paper presented at: American Psychiatric Association Annual Meeting; 2013 May 20; San Francisco, CA.
Bromley E, Adams GF, Brekke JS. A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 2013 Apr 26; 24(2):125-40.
Kasckow JW, Haas GL, Cornelius J, Luther J. Telehealth monitoring of suicidal ideation in patients with schizophrenia. Poster session presented at: International Congress on Schizophrenia Research; 2013 Apr 23; Orlando, FL.
Kukla ME, Lysaker P. Metacognition and the subjective experience of recovery in schizophrenia. Poster session presented at: International Congress on Schizophrenia Research; 2013 Apr 21; Orlando, FL.
Kukla M, Salyers MP, Lysaker PH. Levels of patient activation among adults with schizophrenia: associations with hope, symptoms, medication adherence, and recovery attitudes. The Journal of nervous and mental disease. 2013 Apr 1; 201(4):339-44.
Kasckow JW, Luther J, Fox L, Loganathan M, Haas GL. Telehealth monitoring of older patients with schizophrenia at risk for suicide. Presented at: American Association for Geriatric Psychiatry Annual Meeting; 2013 Mar 15; Los Angeles, CA.
Ganzini LK. Delirium and End of Life Care in Patients with Schizophrenia. Paper presented at: Academy of Psychosomatic Medicine Annual Meeting; 2012 Nov 17; Atlanta, GA.
Ganzini L, Mansoor D, Socherman R, Duckart J. Delirium and decisional incapacity in veterans with schizophrenia and medical illness. General hospital psychiatry. 2012 Sep 1; 34(5):506-9.
Owen RR, Hudson TJ, Thrush CR, Williams DK, Armitage TL. An Intervention to Implement Medication Management Recommendations of Schizophrenia Guidelines. Paper presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 19; National Harbor, MD.
Kasckow J, Mrkva A, Rotondi A, Chinman M, Fox L, Loganathan M, Haas G, Zickmund S. Optimizing scripted dialogues for an e-health intervention for suicidal Veterans with schizophrenia: a “user design” approach using qualitative methods. Poster session presented at: VA / Department of Defense Suicide Prevention Annual Conference; 2012 Jun 20; Washington, DC.
Kasckow J, Liu N, Phillips MR. Case-control study of the relationship of functioning to suicide in a community-based sample of individuals with schizophrenia in China. Community mental health journal. 2012 Jun 1; 48(3):317-20.
Kasckow JW, Golshan S, Zisook S. Subsyndromal depressive symptoms in middle aged and older patients with schizophrenia: relationship to suicidal ideation. Paper presented at: American Association for Geriatric Psychiatry Annual Meeting; 2012 Mar 18; Washington, DC.
Bromley E. The texture of the real: experimentation and experience in schizophrenia. Culture, Medicine and Psychiatry. 2012 Mar 1; 36(1):154-74.
Outcalt SD, Lysaker PH. The relationships between trauma history, trait anger, and stigma in persons diagnosed with schizophrenia spectrum disorders. Psychosis. 2012 Feb 9; 4(1):32-41.
Herrold AA, Napier TC. Role of mGluR5 in stimulant addiction, schizophrenia co-morbidity, and neurogenesis. In: Olive MF, editor. Drug Addiction & Adult Neurogenesis. Karala, India: Research Signpost/Transworld Research Network Publishers; 2011. Chapter 3. 41-68 p.
Rotondi AJ. Effectiveness of web-based family psychoeducational therapy delivered to the homes of persons with schizophrenia and their family members. Paper presented at: Institute on Psychiatric Services Annual Meeting; 2011 Oct 27; San Francisco, CA.
Olfson M, Ascher-Svanum H, Faries DE, Marcus SC. Predicting psychiatric hospital admission among adults with schizophrenia. Psychiatric services (Washington, D.C.). 2011 Oct 1; 62(10):1138-45.
Kasckow JW, Appelt C, Felmet K, Daley D, Haas G. Development a coping manual for Veterans with schizophrenia and suicidal behaviors: qualitative findings. Paper presented at: VA Mental Health Annual Conference; 2011 Aug 25; Baltimore, MD.
Rost K, Hsieh YP, Xu S, Menachemi N, Young AS. Potential disparities in the management of schizophrenia in the United States. Psychiatric services (Washington, D.C.). 2011 Jun 1; 62(6):613-8.
Kasckow JW, Liu N, Phillips M. Case-control study of the relationship of functioning to suicide in a community-based sample of individuals with schizophrenia in China. Paper presented at: American Psychiatric Association Annual Meeting; 2011 May 16; Honolulu, HI.
Kasckow JW, Haas G, Appelt C, Daley D, Felmet K, Haas G. Development of a coping manual for individuals with schizophrenia and suicidal behaviors. Paper presented at: VA / Department of Defense Suicide Prevention Annual Conference; 2011 Mar 16; Boston, MA.
Kasckow JW, Haas G, Gurklis J. A telehealth intervention for suicidal Veterans with schizophrenia. Paper presented at: VA / Department of Defense Suicide Prevention Annual Conference; 2011 Mar 16; Boston, MA.
Lysaker PH, Davis LW, Buck KD, Outcalt S, Ringer JM. Negative symptoms and poor insight as predictors of the similarity between client and therapist ratings of therapeutic alliance in cognitive behavior therapy for patients with schizophrenia. The Journal of nervous and mental disease. 2011 Mar 1; 199(3):191-5.
Zeber JE, Copeland LA, Miller AL, Valenstein M, Leykum L. Cost-Benefit Analysis of Higher medication Copayments in Veterans with Schizophrenia. [Abstract]. Journal of Mental Health Policy and Economics. 2011 Mar 1; 14(S1):S39-S39.
Felmet K, Zisook S, Kasckow JW. Elderly patients with schizophrenia and depression: diagnosis and treatment. Clinical schizophrenia & related psychoses. 2011 Jan 1; 4(4):239-50.
Osatuke K, Reid M, Stiles WB, Kasckow JW, Zisook S, Mohamed S. Narrative evolution and assimilation of problematic experiences in a case of pharmacotherapy for schizophrenia. Psychotherapy research : journal of the Society for Psychotherapy Research. 2011 Jan 1; 21(1):41-53.
Copeland LA, Parchman ML, Zeber JE, Lawrence VA, Downs JR, Miller AL. Prediabetes assessment and follow-up in older veterans with schizophrenia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2010 Oct 1; 18(10):887-96.
Hamilton A, Cohen AN, Young AS. Women with Schizophrenia Who Use Outpatient VA Clinics. Poster session presented at: VA HSR&D Field-Based Women's Health Meeting; 2010 Jul 14; Arlington, VA.
Olfson M, Marcus SC, Doshi JA. Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. The Journal of clinical psychiatry. 2010 Jul 1; 71(7):831-8.
Salyers MP. Coping with positive and negative symptoms of schizophrenia. American Journal of Psychiatric Rehabilitation. 2010 Jul 1; 13(1):208-223.
Ganzini LK. End of Life Care for Patients with Cancer and Schizophrenia. Poster session presented at: VA HSR&D Field-Based Mental Health and Substance Use Disorders Meeting; 2010 Apr 28; Little Rock, AR.
Young AS, Hamilton A, Cohen AN. Evaluating Implementation of Evidence-Based Care for Schizophrenia. Paper presented at: National Institutes of Health Conference on the Science of Dissemination and Implementation: Methods and Measurement; 2010 Mar 15; Bethesda, MD.
Cohen AN, Glynn SM, Hamilton AB, Young AS. Implementation of a family intervention for individuals with schizophrenia. Journal of general internal medicine. 2010 Jan 1; 25 Suppl 1:32-7.
Ganzini L, Socherman R. Cancer Care for Patients with Schizophrenia. In: Holland JC, editor. Psycho-oncology. 2nd ed. Oxford, United Kingdom: Oxford University Press; 2010. Chapter 49. 363-368 p.
Rotondi AJ. Schizophrenia. In: Cucciare MA, Weingardt KR, editors. Using Technology to Support Evidence-based Behavioral Health Practices - A Clinician's Guide. New York, NY: Taylor and Francis Group; 2009. Chapter 4. 69-90 p.
Shim R, Rust G, Sambamoorthi U. Schizophrenia and Diabetes: A High Impact Comorbidity Cluster. Poster session presented at: Disease Management Association of America Care Continuum Alliance Annual Forum; 2009 Sep 21; San Diego, CA.
Zeber JE, Copeland LA, Miller AL, Valenstein M, Leykum L. A cost-benefit analysis of higher medication copayments in veterans with schizophrenia. Poster session presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Chicago, IL.
Fortney JC, Xu S, Dong F. Community-level correlates of hospitalizations for persons with schizophrenia. Psychiatric services (Washington, D.C.). 2009 Jun 1; 60(6):772-8.
Zeber JE, Copeland LA, Miller AL, Valenstein M, Leykum L. A cost-benefit analysis of higher medication copayments in veterans with schizophrenia. Paper presented at: International Congress on Schizophrenia Research; 2009 Mar 28; San Diego, CA.
Frueh BC, Grubaugh AL, Cusack KJ, Kimble MO, Elhai JD, Knapp RG. Exposure-based cognitive behavioral treatment of PTSD in adults with schizophrenia or schizoaffective disorder. Poster session presented at: Anxiety Disorders Association of America Annual Conference; 2009 Mar 15; Santa Ana Pueblo, NM.
Young AS, Brown AH, Cohen AN, Chinman MJ, Reist C. Implementing Treatment Guidelines in Schizophrenia: Process Evaluation of Implementation in EQUIP. Poster session presented at: VA QUERI National Meeting; 2008 Dec 8; Phoenix, AZ.
Long ME, Grubaugh AL, Elhai JD, Knapp RG, Frueh BC. Therapist fidelity with an exposure-based treatment of PTSD in adults with Schizophrenia or Schizoaffective Disorder. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2008 Nov 15; Orlando, FL.
Young AS, Hamilton-Brown A, Chinman MJ, Cohen AN, Reist C. Improving Care for Schizophrenia: Process Evaluation of Implementation in EQUIP. Poster session presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2008 Jul 22; Arlington, VA.
Smith JL, Spollen JJ, Owen RR. Facilitation in Implementing Evidence-Based Practices for Schizophrenia: Researcher & Clinical Leader Perspectives. Paper presented at: University of Alberta Knowledge Translation Annual Forum; 2008 Jun 12; Alberta, Canada.
Owen RR, Smith JL, Hudson TJ, Curran GM. Comparison of Strategies to Improve Antipsychotic Monitoring and Management for Schizophrenia. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 8; Washington, DC.
Zeber JE, Copeland LA, Miller AL, Kilbourne AM, Velligan DI, Mortensen EM. Ethnicity and the impact of higher medication copayments among veterans with schizophrenia. Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2008 May 3; Toronto, Canada.
Zeber JE, Valenstein M, Miller AL, Stensland M. The cost-offset effect of a copayment increase among veterans with schizophrenia. Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2008 May 1; Toronto, Canada.
Allwine R, Eon S, Zillich AJ, Ott C. Rates of Adherence to Antipsychotic Medications in a Population of Patients with Bipolar Disorder or Schizophrenia in a Community Mental Health Setting: Evaluation of 60-Day Refill Data. Presented at: College of Psychiatric and Neurologic Pharmacists Annual Meeting; 2008 Apr 13; Scottsdale, AZ.
Pyne JM, Labbate C. Ranking of outcome domains for use in real-time outcomes feedback laboratory by patients with schizophrenia. The Journal of nervous and mental disease. 2008 Apr 1; 196(4):336-9.
Zeber JE, Copeland LA, Miller AL, Kilbourne AM, Velligan DI, Mortensen EM. Ethnicity and the impact of higher medication copayments among patients with schizophrenia. Poster session presented at: RWJ Foundation Critical Research Issues in Latino Mental Health Annual Conference; 2008 Mar 10; Santa Fe, NM.
Brown AH, Cohen AN, Chinman MJ, Kessler C, Young AS. EQUIP: implementing chronic care principles and applying formative evaluation methods to improve care for schizophrenia: QUERI Series. Implementation science : IS. 2008 Feb 15; 3:9.
Owen RR, Smith JL, Hudson TJ, Curran GM. Comparison of Strategies to Improve Antipsychotic Monitoring and Management for Schizophrenia. Paper presented at: VA HSR&D National Meeting; 2008 Feb 13; Baltimore, MD.
Young AS, Niv N, Cohen AN, Mintz J, Ventura J. The validity of using patient self-report to assess psychotic symptoms in schizophrenia. Poster session presented at: VA HSR&D National Meeting; 2008 Feb 12; Baltimore, MD.
Hudson TJ, Owen RR, Thrush CR, Armitage TL, Thapa P. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. The Journal of clinical psychiatry. 2008 Jan 1; 69(1):74-80.
Lysaker PH, Salyers MP, Tsai J, Spurrier LY, Davis LW. Clinical and psychological correlates of two domains of hopelessness in schizophrenia. Journal of rehabilitation research and development. 2008 Jan 1; 45(6):911-9.
Lysaker PH, Salyers MP. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatrica Scandinavica. 2007 Oct 1; 116(4):290-8.
Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics. 2007 Sep 1; 48(5):412-7.
Young AS. Implementing Recovery-Oriented, Evidence-Based Practices in Schizophrenia. Paper presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2007 Jul 19; Alexandria, VA.
Smith JL, Spollen JJ, Owen RR. Facilitation in Implementing Evidence-Based Practices for Schizophrenia: Researcher & Clinical Leader Perspectives. Presented at: VA Transforming Mental Health Care Conference; 2007 Jul 18; Alexandria, VA.
Smith JL, Spollen JJ, Owen RR. Facilitation in Implementing Evidence-Based Practices of Schizophrenia: Researcher & Clinical Leader Perspectives. Presented at: AcademyHealth Annual Research Meeting; 2007 Jun 3; Orlando, FL.
Hudson TJ. Schizophrenia. In: PharmPrep 3rd Edition: Case-Based Board Review. AMerican Society of Health-systems pharmacists; 2007. 280-285 p.
Garman PM, Ried LD, Bengtson MA, Hsu C, McConkey JR. Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia. Journal of the American Pharmacists Association : JAPhA. 2007 May 1; 47(3):373-8.
Garman PM, Ried LD, Bengston MA, Hsu C. Monitoring Glucose Regulation Parameters in Veterans Living with Schizophrenia-Related Disorders and Switched from One Second-Generation Antipsychotic to Another. Poster session presented at: Academy of Managed Care Pharmacy Annual Meeting; 2007 Apr 13; San Diego, CA.
Copeland LA, Lawrence VA, Zeber JE, Mortensen, EM. Surgery rates among veterans with schizophrenia. Poster session presented at: International Congress on Schizophrenia Research; 2007 Mar 28; Colorado Springs, CO.
Ried LD. Lipid Profile Monitoring In Veterans Living With Schizophrenia-Related Disorders And Treated With Second-Generation Antipsychotics: Findings From A VA-Based Population. Poster session presented at: American Pharmaceutical Association Annual Meeting; 2007 Mar 17; Atlanta, GA.
Copeland LA. First year of the VA HSR&D career development award: Patterns of late-life healthcare among VA patients with schizophrenia. Paper presented at: VA HSR&D National Meeting; 2007 Feb 21; Arlington, VA.
Niv N, Cohen AN, Mintz J, Ventura J, Young AS. The validity of using patient self-report to assess psychotic symptoms in schizophrenia. Schizophrenia Research. 2007 Feb 1; 90(1-3):245-250.
Glynn SM, Cohen AN, Niv N. New challenges in family interventions for schizophrenia. Expert Review of Neurotherapeutics. 2007 Jan 1; 7(1):33-43.
Yanos PT, Moos RH. Determinants of functioning and well-being among individuals with schizophrenia: an integrated model. Clinical Psychology Review. 2007 Jan 1; 27(1):58-77.
Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. Journal of general internal medicine. 2006 Nov 1; 21(11):1133-7.
Carney P, Jones E. A Controlled Study of Medical Comorbidity In Women and men with Schizophrenia and Schizoaffective Disorder. Journal of general internal medicine. 2006 Nov 1; 21(11):A-10-A-10.
Wu EQ, Shi L, Birnbaum H, Hudson T, Kessler R. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychological medicine. 2006 Nov 1; 36(11):1535-40.
Lambert BL, Cunningham FE, Miller DR, Dalack GW, Hur K. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. American journal of epidemiology. 2006 Oct 1; 164(7):672-81.
Young AS, Cohen AN, Kessler C, McNagny K, Reist C, Mintz J. Implementing best practices to improve care for schizophrenia (EQUIP). Paper presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2006 Sep 1; Portland, OR.
Compton MT, Esterberg ML, Druss BG, Walker EF, Kaslow NJ. A descriptive study of pathways to care among hospitalized urban African American first-episode schizophrenia-spectrum patients. Social psychiatry and psychiatric epidemiology. 2006 Jul 1; 41(7):566-73.
Cohen AN, Glynn S, Brown AH, Young AS. Involving families in the care of patients with schizophrenia: Patient and provider barriers. Paper presented at: AcademyHealth Annual Research Meeting; 2006 Jun 1; Seattle, WA.
Cohen AN, Young AS. EQUIP: Evaluating a chronic illness care model for schizophrenia. Paper presented at: AcademyHealth Annual Research Meeting; 2006 Jun 1; Seattle, WA.
McCarthy JF, Kales HC, Sajatovic M, Jeste DV, Ignacio R, Blow FC. New-Onset Schizophrenia Among Veterans: Prevalence and Patient Characteristics. Paper presented at: American Association for Geriatric Psychiatry Annual Meeting; 2006 Mar 12; San Juan, Puerto Rico.
Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Molecular Psychiatry. 2006 Mar 1; 11(3):241-51.
Burke RE, Walsh J, Matzilevich D, Benes FM. Mapping of hippocampal gene clusters regulated by the amygdala to nonlinkage sites for schizophrenia. Molecular Psychiatry. 2006 Feb 1; 11(2):158-71.
Ren XS, Qian S, Lee AF, Herz L, Miller DR, Kazis LE. Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents. Journal of clinical pharmacy and therapeutics. 2006 Feb 1; 31(1):57-65.
Young AS, Cohen AN, Mintz J. Evaluating a chronic care model designed to improve treatment for schizophrenia (EQUIP). Paper presented at: VA HSR&D National Meeting; 2006 Feb 1; Arlington, VA.
Petrakis IL, Leslie D, Finney JW, Rosenheck R. Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2006 Jan 1; 15(1):44-9.
Yu W, Ren XS, Lee AF, Herz L, Huang YH, Kazis LE. Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophrenia. Pharmacoeconomics. 2006 Jan 1; 24(12):1233-48.
Ren XS, Qian S, Lee AF. Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents. Paper presented at: International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2005 Nov 6; Florence, Italy.
Cohen AN, Young AS, Mintz J. Evaluating an Intervention to improve the quality of care in schizophrenia. Paper presented at: AcademyHealth Annual Research Meeting; 2005 Jun 1; Boston, MA.
Owen RR, Smith JL, Young AS. Mental Health QUERI: Improving Treatment for Schizophrenia. Paper presented at: VA MIRECC Annual Conference; 2005 Jun 1; New Orleans, LA.
Young AS, Cohen AN, Mintz J. Information systems and improving care for schizophrenia. Paper presented at: AcademyHealth Annual Research Meeting; 2005 Jun 1; Boston, MA.
Butterfield MI, Zervakis J, Strauss J, Lieberman J, Marx CE. Neuroactive Steroids and Suicidality in Schizophrenia and Schizoaffective Disorder. Poster session presented at: American Psychiatric Association Annual Meeting; 2005 May 15; Atlanta, GA.
Blow FC, McCarthy JF, Valenstein M, Smelson D, Reist C. Use of Atypical Antipsychotics Among VA patients with Schizophrenia: National Trends. Poster session presented at: International Congress on Schizophrenia Research; 2005 Apr 1; Savannah, GA.
Fischer EP, McSweeney JC, Pyne JM, Yates T. Veteran's views on sustaining involvement in care for schizophrenia. Poster session presented at: International Congress on Schizophrenia Research; 2005 Apr 1; Savannah, GA.
Kreyenbuhl J, Valenstein M, McCarthy JF, Ganoczy D, Blow FC. Patterns of combination antipsychotic treatment for veterans with schizophrenia. Poster session presented at: International Congress on Schizophrenia Research; 2005 Apr 1; Savannah, GA.
Zeber J, Grazier KL, Blow FC, Valenstein M, Lantz PM. The effect of a medication co-payment increase on veterans with schizophrenia. Poster session presented at: International Congress on Schizophrenia Research; 2005 Apr 1; Savannah, GA.
Russo PA, Smith MW, Namjoshi M. Health care costs for schizophrenia patients started on olanzapine versus risperidone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2005 Mar 15; 62(6):610-5.
Ren XS, Huang YH, Lee AF, Miller DR, Qian S, Kazis L. Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia. Journal of clinical pharmacy and therapeutics. 2005 Feb 1; 30(1):65-71.
Young AS, Mintz J, Cohen AN, Chinman MJ. A network-based system to improve care for schizophrenia: the Medical Informatics Network Tool (MINT). Journal of the American Medical Informatics Association : JAMIA. 2004 Sep 1; 11(5):358-67.
Young AS, Cohen AN, Chinman MJ, Mintz J. Informatics to Improve Care for Schizophrenia. Paper presented at: VA Information Technology Annual Conference; 2004 Aug 1; Austin, TX.
Costanzo ES, Antes LM, Christensen AJ. Behavioral and medical treatment of chronic polydipsia in a patient with schizophrenia and diabetes insipidus. Psychosomatic medicine. 2004 May 1; 66(2):283-6.
Strauss JL, Calhoun PS, Marx CE, Butterfield MI. Comorbid PTSD linked to suicidality among veterans with schizophrenia. Paper presented at: American Psychiatric Association Annual Meeting; 2004 May 1; New York, NY.
Zeber J, Copeland L, Blow F, Smelson D. Atypical Antipsychotics and Schizophrenia with Comorbid Substance Abuse. Paper presented at: American Psychiatric Association Annual Meeting; 2004 May 1; New York, NY.
Young AS, Mintz J, Cohen AN. Using information systems to improve care for persons with schizophrenia. Psychiatric services (Washington, D.C.). 2004 Mar 1; 55(3):253-255.
Roll JM, Chermack ST, Chudzynski JE. Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study. Psychiatry Research. 2004 Jan 30; 125(1):61-4.
Fischer EP, McSweeney J, Pyne JM, Mullings R, Yates T, Naylor AJ. Stakeholder perspectives on sustaining involvement in care for schizophrenia: Autonomy, boredom and decision-making. Paper presented at: International Congress on Schizophrenia Research; 2003 Apr 2; Colorado Springs, CO.
Owen RR, Curran GM, Marder SR, Ritchie M. Translating research into practice: Improving medication management for schizophrenia. Paper presented at: VA HSR&D National Meeting; 2003 Feb 14; Washington, DC.
Khanuja K, Austin K, Blow F, Owen R, Valenstein M. Treatment and Outcomes of Patients with Co-morbid Depression and Schizophrenia. Paper presented at: VA HSR&D National Meeting; 2003 Feb 1; Washington, DC.
Owen RR, Cannon D, Thrush CR. Mental Health QUERI Initiative: expert ratings of criteria to assess performance for major depressive disorder and schizophrenia. American journal of medical quality : the official journal of the American College of Medical Quality. 2003 Jan 1; 18(1):15-20.
Barry KL, Blow FC, Dornfeld M, Valenstein M. Aging and schizophrenia: current health services research and recommendations. Journal of geriatric psychiatry and neurology. 2002 Sep 1; 15(3):121-7.
Milner KK, Valenstein M. A comparison of guidelines for the treatment of schizophrenia. Psychiatric services (Washington, D.C.). 2002 Jul 1; 53(7):888-90.
Fischer EP, Shumway M, Owen RR. Priorities of consumers, providers, and family members in the treatment of schizophrenia. Psychiatric services (Washington, D.C.). 2002 Jun 1; 53(6):724-9.
Owen RR, Thrush CR, Hudson TJ, Mallory SR, Fischer EP, Clardy JA, Williams DK. Using an explicit guideline-based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia. International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua. 2002 Jun 1; 14(3):199-206.
Sajatovic M, Sultana D, Bingham CR, Buckley P, Donenwirth K. Gender related differences in clinical characteristics and hospital based resource utilization among older adults with schizophrenia. International journal of geriatric psychiatry. 2002 Jun 1; 17(6):542-8.
Young AS, Marder SR. Using collaborative care models to improve the treatment of schizophrenia. Paper presented at: American Psychiatric Association Annual Meeting; 2002 May 21; Philadelphia, PA.
Fischer EP. Family consumer and provider agreement on outcome priorities and service preferences in schizophrenia. Paper presented at: VA MIRECC Annual Retreat; 2002 Apr 24; Jackson, MS.
Hudson TJ. Optimizing medication adherence interventions for schizophrenia. Paper presented at: College of Psychiatric and Neurologic Pharmacists Annual Meeting; 2002 Apr 19; Seattle, WA.
Barry KL, Blow F, Welsh D, Brockmann LM. Gender Differences in the Diagnosis and Treatment of Schizophrenia and Other Serious Mental Illnesses in the VHA: Special Issues for Women Veterans. Paper presented at: VA MIRECC on Women and Schizophrenia Annual Conference; 2002 Apr 15; Washington, DC.
Fischer EP, Shumway M. Agreement on goals, consumer preferences, and involvement in care for schizophrenia. Paper presented at: National Institute of Mental Health Mental Health Services Research Annual Conference; 2002 Apr 2; Washington, DC.
Pyne JM, Sullivan G, Kaplan RM, Williams DK. Sensitivity of generic effectiveness measures to improvement in schizophrenia symptom severity. Paper presented at: VA HSR&D National Meeting; 2002 Feb 14; Washington, DC.
Russo P, Smith MW. Quality of life in schizophrenia: the relationship between participant self-report and clinical assessment. Paper presented at: AcademyHealth Annual Research Meeting; 2002 Feb 1; Washington, DC.
Russo P, Smith MW, Namjoshi M. Changes in schizophrenia-related total direct medical costs following initiating of olanzapine or resperidone in a privately insured population in the United States. Paper presented at: Collegium Internationale Neuro-Psychopharmacolgicum Annual Congress; 2002 Feb 1; Montréal, Canada.
Russo P, Smith MW, Namjoshi M, Cavazzoni P, Brier A. Changes in antidiabetic medication use following initiation of olanzapine or risperidone among persons with schizophrenia. Paper presented at: American College of Neuropsychopharmacology Annual Meeting; 2002 Feb 1; San Juan, Puerto Rico.
Cradock J, Young AS, Sullivan G. The accuracy of medical record documentation in schizophrenia. The journal of behavioral health services & research. 2001 Nov 1; 28(4):456-65.
Pyne JM, Sullivan G, Kaplan RM, Williams DK. Comparing the sensitivity of generic effectiveness measures to symptom improvement in person with schizophrenia. Paper presented at: Society for Medical Decision Making Annual Meeting; 2001 Oct 31; San Diego, CA.
Fischer EP, Shumway M. Do stakeholders agree on priorities in treatment for schizophrenia? Extent of agreement within individual consumer-provider-family sets. Paper presented at: International Congress on Schizophrenia Research; 2001 Sep 25; Whistler, Canada.
Hudson TJ. Schizophrenia. In: Ginsburg DB, editor. PharmPrep 1st Edition: Case-Based Board Review. Bethesda, MD: American Society of Health-system Pharmacists; 2001. 280-285 p.
Cradock JA, Young AS, Sullivan G. The accuracy of medical record documentation in schizophrenia. Paper presented at: Western Psychological Association Annual Convention; 2001 Jul 1; Maui, HI.
Cradock JA, Young AS, Sullivan G. The accuracy of medication treatment for schizophrenia. Paper presented at: AcademyHealth Annual Research Meeting; 2001 Jun 11; Atlanta, GA.
Pyne JM, Sullivan G, Williams DK. Quality-adjusted life year measurement in persons with schizophrenia. Paper presented at: American Psychological Association Annual Convention; 2001 May 14; New Orleans, LA.
Young AS, Sullivan G. The quality of medication treatment for schizophrenia. Paper presented at: American Psychiatric Association Annual Meeting; 2001 May 8; New Orleans, LA.
Owen RR. Closing the efficacy/effectiveness gap in psychopharmacology: Strategies for implementing schizophrenia guidelines. Paper presented at: American Psychiatric Association Annual Meeting; 2001 May 1; New Orleans, LA.
Pyne JM, Bean D, Sullivan G. Characteristics of patients with schizophrenia who do not believe they are mentally ill. The Journal of nervous and mental disease. 2001 Mar 1; 189(3):146-53.
Fischer EP, Shumway M. Stakeholder preferences in schizophrenia: Agreement within consumer-provider-family sets. Paper presented at: VA HSR&D National Meeting; 2001 Feb 19; Washington, DC.
Pyne JM, Sullivan G, Kaplan RM, Williams DK. Comparison of generic effectiveness measures in veterans with schizophrenia. Paper presented at: VA HSR&D National Meeting; 2001 Feb 19; Washington, DC.
Owen RR, Thrush CR, Kirchner JE, Fischer EP, Booth BM. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua. 2000 Dec 1; 12(6):475-82.
Fischer EP. Schizophrenia outcome priorities and treatment preferences: Agreement among stakeholders. Paper presented at: Association for Health Services Research Annual Meeting; 2000 Jun 15; Los Angeles, CA.
Roberts JS, Blow FC, Copeland LA, Barry KL, Van Stone W. Age-group differences in treatment outcomes for male veterans with severe schizophrenia: a three-year longitudinal study. Journal of geriatric psychiatry and neurology. 2000 Jun 1; 13(2):78-86.
Hudson TJ, Owen RR, Mason BL, Lancaster AE. Use of computerized data to assess adherence to schizophrenia practice guidelines. Presented at: VA HSR&D National Meeting; 1999 Sep 15; Washington, DC.
Pyne JM. WHO Disablement Assessment Schedule: An application in schizophrenia. Paper presented at: American Psychiatric Association Annual Workshop; 1999 Aug 15; Washington, DC.
Hudson TJ, Owen RR, Lancaster AE, Mason L. The feasibility of using automated data to assess guideline-concordant care for schizophrenia. Journal of medical systems. 1999 Aug 1; 23(4):299-307.
Kales HC, Dequardo JR, Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 1999 Apr 1; 23(3):547-56.
Mares A, McGuire J. Recidivism among Veterans with Schizophrenia Living in Board and Care: An Outcome Evaluation of the Community Residential Care Program. Paper presented at: VA HSR&D National Meeting; 1999 Feb 24; Washington, DC.
Kirchner JE, Owen RR, Nordquist C, Fischer EP. Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric services (Washington, D.C.). 1998 Jan 1; 49(1):82-5.